Mifenti Vaginal Capsule is a sterile, single-dose, delayed-release capsule formulation containing 600mg of fenticonazole as the active ingredient. It is indicated for the local treatment of vaginal yeast infections caused by Candida species, including Candida albicans, Candida glabrata, and Candida tropicalis. The product is designed to release the active ingredient over a prolonged period, providing sustained antifungal activity against the infecting Candida species. The capsule shell is made of a combination of materials, including gelatin and other inactive ingredients, and is designed to dissolve in the vaginal environment. The treatment duration is typically 3-5 days, although the exact duration may vary depending on the severity and progression of the infection. Mifenti Vaginal Capsule is available in a sterile, single-dose package and should be inserted high into the posterior fornix of the vagina, where it will dissolve and release the active ingredient.